United States: Tenth Circuit Finally Shuts The Door Completely On Cerevny

Last Updated: August 21 2019
Article by Michelle Yeary

We've been posting about this case since 2016 when the district court first dismissed plaintiff's failure to warn claim as preempted on the grounds that there was clear evidence the FDA would have rejected the warning plaintiff sought. We celebrated again in 2017 when the Tenth Circuit affirmed that decision. Since then we've been waiting to see what would happen to the claims the Tenth Circuit remanded. The wait is over. The remaining claims are not recognized under Utah law.

A quick reminder first. The case involves the drug Clomid which has been FDA approved and on the market since 1967 and is prescribed to women to induce ovulation. Plaintiff was prescribed Clomid in 1992 and took Clomid only prior to becoming pregnant. Plaintiff's son was born with serious birth defects which plaintiff alleges were caused by Clomid. Cerevny v. Aventis, Inc., 2019 WL 3763441, *1 (10th Cir. Aug. 9, 2019). Remaining on this appeal are claims for failure to warn of the risk of using Clomid during pregnancy, fraud, and negligent misrepresentation. Id.

Before the court even considers the legal viability of these remaining claims, it notes that plaintiff's prior claim for failure to warn of the risk of birth defects from pre-pregnancy use of Clomid was dismissed because there was clear evidence that the FDA would have rejected any such warning. That earlier decision was based on FDA's rejection of a Citizen's Petition in 2012 requesting that just such a warning be added. Id. at *3. Plaintiff argued to the court that the Supreme Court's decision in Merck Sharp & Dohme Corp. v. Albrecht, — U.S. —, 139 S. Ct. 1668 (2019) undercuts this earlier preemption decision. Cerevny at *7 n.9. Plaintiff argues that Albrecht held "that only labeling changes sought by the manufacturer can lead to preemption." Id. In other words, clear evidence can't be the rejection of a Citizen's Petition. The argument is erroneously based on the following from Albrecht:

In a case like Wyeth, showing that federal law prohibited the drug manufacturer from adding a warning that would satisfy state law requires the drug manufacturer to show that it fully informed the FDA of the justifications for the warning required by state law and that the FDA, in turn, informed the drug manufacturer that the FDA would not approve changing the drug's label to include that warning.

Albrecht, 139 S.Ct. at 1678. But plaintiff relies solely on the "requires the drug manufacturer to show that it fully informed the FDA," without putting it in context as the Supreme Court did with its preface "[i]n a case like Wyeth." We pointed out this exact issue in one of our post-Albrecht posts. Albrecht does not address situations where the FDA was "fully informed" (or not) by someone else, such as through a third-party Citizen's Petition. Those weren't the facts before the Court and the decision clearly emphasized it was based on the "particular set of circumstances" in Wyeth. Id. Now we have circuit court authority to back us up:

Here, Aventis argues a different ground to show that the FDA would have rejected the Cervenys' proposed warning. Unlike Wyeth, Aventis is not left to show clear evidence that the FDA would have rejected any unilateral label change under the CBE regulation, but Aventis has a separate avenue—the FDA's unequivocally having rejected Terry Mix's citizen petition advocating for the warning that the Cervenys now assert. We see nothing in Wyeth or Albrecht excluding Aventis from justifying preemption on this basis.

Cerevny, at *7 n.9 (citation omitted).

Moving back to the substance of the claims on appeal, plaintiff's primary claim is that defendant failed to warn about the risk of using Clomid during pregnancy and that that breach caused the alleged injury. Id. at *5. But it is undisputed that plaintiff did not use Clomid during her pregnancy. So, what plaintiff is actually arguing is that if the manufacturer had warned about condition X, plaintiff wouldn't have used the product, and therefore wouldn't have suffered from condition Y. Neither the district court nor the Tenth Circuit could find any law to support that Utah would recognize a failure to warn claim based on risk plaintiff never encountered. The Tenth Circuit also cited an Erie-rationale for not "expanding" Utah law to adopt this "unusual theory." Id.

Furthermore, both courts also found that plaintiff's theory wouldn't survive because the 1992 label for Clomid adequately warned of the risk of birth defects if used during pregnancy. "Simply put, the warning about the risk of ingesting Clomid during pregnancy sufficed even if it did not frighten [plaintiff] from using Clomid before pregnancy." Id.

Plaintiff's remaining fraud and misrepresentation claims were based entirely on the opening sentence to the Contraindications section of the label:

Although no causative evidence of a deleterious effect of Clomid (clomiphene citrate) therapy on the human fetus has been seen, such evidence in regard to the rat and rabbit has been presented (see Animal Pharmacology and Toxicology).

Id. at *6. But plaintiff ignores the remainder of the paragraph that goes on to detail the risk of fetal harm if used during pregnancy and how to avoid the risk. Moreover, deleting the first sentence would not "sound an alarm about risk to a fetus from a mother's ingesting Clomid before pregnancy" — the only risk at issue in this case. Id.

Also, in assessing the veracity of the sentence plaintiff focuses on, the court again acknowledged that the FDA had reviewed the data in 2007 and 2009 and "concluded that the data is insufficient to demonstrate reasonable evidence of an association between [the drug] and congenital abnormalities." Id. In fact the warning remains nearly the same today.

We wondered back in 2017 whether plaintiff would appeal the preemption decision, but instead she played out the remaining claims back at the district court and now again at the circuit level. The case is fully resolved now. So, we ask again – does plaintiff roll the dice?

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions